HIV, Trump and AIDS
Digest more
2don MSN
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, lenacapavir, as a tool in their efforts to fight HIV infections – especially for groups most at risk and in areas where the burden of HIV remains high.
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV infection. The recommendation, issued at the International AIDS Conference in Kigali,
4h
News-Medical.Net on MSNMany HIV-exposed newborns miss preventive treatment after birthNewborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after delivery to reduce the risk of transmission from mother to child.
32mon MSN
State attorneys general and federal prosecutors alleged Gilead Sciences illegally bankrolled lavish events for prescribers.
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with the Medicines Patent Pool to allow generic production of its long-acting injectable HIV treatment cabotegravir.
Explore more
Freda Jones, founder of LOTUS, empowers women living with HIV in Atlanta through a peer-led support group. Peer support is crucial for HIV care.
According to the ESSJ, the national treatment cascade, as at last December, shows that 90.0 per cent of all persons living with HIV knew their status, 75.0 per cent were linked to care, 62.0 per cent were retained in care, and 58.0 per cent retained on ARVs.
This story was originally published by The Institute for Public Service Reporting Memphis. Healthcare providers across Tennessee are scrambling to find new funding for HIV prevention following the loss of a critical federal grant.
Pharma giant Gilead Sciences agreed to pay hundreds of millions of dollars to state health insurance programs after admitting to a years-long kickback scheme to promote its panel of HIV medications. The California-based drug company reached a $202 million settlement with a coalition of 49 states led by New York for incentivizing doctors to prescribe its HIV meds with hundreds of thousands of dollars in payments,